What is JD Health International Operating Cash Flow per Share?
JD Health International's operating cash flow per share for the
six
months ended in Dec. 2023 was HK$1.46.
JD Health International's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.59.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of JD Health International was -24.10% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -7.10% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 95.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for JD Health International's Operating Cash Flow per Share or its related term are showing as below:
HKSE:06618'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -7.1 Med: 157.15 Max: 421.5
Current: -7.1
During the past 7 years, JD Health International's highest 3-Year average Operating Cash Flow per Share Growth Rate was 421.50% per year. The lowest was -7.10% per year. And the median was 157.15% per year.
HKSE:06618's 3-Year OCF Growth Rate is ranked worse than 73.18% of 481
companies
in the Healthcare Providers & Services industry
Industry Median: 9.5
vs HKSE:06618: -7.10
JD Health International Operating Cash Flow per Share Historical Data
The historical data trend for JD Health International's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
JD Health International Operating Cash Flow per Share Chart
Competitive Comparison of JD Health International's Operating Cash Flow per Share
For the Medical Care Facilities subindustry, JD Health International's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JD Health International's Price-to-Operating-Cash-Flow Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, JD Health International's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where JD Health International's Price-to-Operating-Cash-Flow falls into.
JD Health International Operating Cash Flow per Share Calculation
Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.
JD Health International's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$1.59
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JD Health International Operating Cash Flow per Share Related Terms
Thank you for viewing the detailed overview of JD Health International's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
JD Health International (HKSE:06618) Business Description
JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health, Ping An Good Doctor, and Meituan for its e-commerce business. As of Dec. 31, 2022, the platform has 154.3 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:06618 has been successfully added to your 